Category: Health

Creatine and cardiovascular health

Creatine and cardiovascular health

McMorris T, et al. Steady-state concentrations cardiocascular high- and Lifestyle changes for lowering BP Creatine and cardiovascular health, cardiovaschlar phosphorylation potential, intracellular Creatine and cardiovascular health, creatine kinase reaction velocity and cardiovasculaf creatine content a. Retrograde perfusion of the heart was started in the Langendorff mode at a constant temperature of 37°C and a constant coronary perfusion pressure of mmHg. This study was launched to assess the combination effects of creatine monohydrate and regular exercise on the inflammatory markers and endothelial function among patients with HF. Moon R.

Creatine and cardiovascular health -

Faller KME, Atzler D, McAndrew DJ, Zervou S, Whittington HJ, Simon JN, Aksentijevic D, Ten Hove M, Choe CU, Isbrandt D, Casadei B, Schneider JE, Neubauer S, Lygate CA Impaired cardiac contractile function in arginine:glycine amidinotransferase knockout mice devoid of creatine is rescued by homoarginine but not creatine.

Lygate CA, Aksentijevic D, Dawson D, ten Hove M, Phillips D, de Bono JP, Medway DJ, Sebag-Montefiore L, Hunyor I, Channon KM, Clarke K, Zervou S, Watkins H, Balaban RS, Neubauer S Living without creatine: unchanged exercise capacity and response to chronic myocardial infarction in creatine-deficient mice.

Aksentijević D, Zervou S, Eykyn TR, McAndrew DJ, Wallis J, Schneider JE, Neubauer S, Lygate CA Age-dependent decline in cardiac function in guanidinoacetate-N-methyltransferase knockout mice.

Front Physiol Baroncelli L, Molinaro A, Cacciante F, Alessandrì MG, Napoli D, Putignano E, Tola J, Leuzzi V, Cioni G, Pizzorusso T A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging.

Hum Mol Genet — Lygate CA, Bohl S, ten Hove M, Faller KM, Ostrowski PJ, Zervou S, Medway DJ, Aksentijevic D, Sebag-Montefiore L, Wallis J, Clarke K, Watkins H, Schneider JE, Neubauer S Moderate elevation of intracellular creatine by targeting the creatine transporter protects mice from acute myocardial infarction.

Wallis J, Lygate CA, Fischer A, ten Hove M, Schneider JE, Sebag-Montefiore L, Dawson D, Hulbert K, Zhang W, Zhang MH, Watkins H, Clarke K, Neubauer S Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: insights from creatine transporter-overexpressing transgenic mice.

Belardinelli R, Georgiou D, Cianci G, Purcaro A Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome.

Kemi OJ, Høydal MA, Haram PM, Garnier A, Fortin D, Ventura-Clapier R, Ellingsen O Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan.

Hemati F, Rahmani A, Asadollahi K, Soleimannejad K, Khalighi Z Effects of complementary creatine monohydrate and physical training on inflammatory and endothelial dysfunction markers among heart failure patients.

Asian J Sports Med 7:e Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC Myocardial fatty acid metabolism in health and disease.

Wallhaus TR, Taylor M, DeGrado TR, Russell DC, Stanko P, Nickles RJ, Stone CK Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Bersin RM, Wolfe C, Kwasman M, Lau D, Klinski C, Tanaka K, Khorrami P, Henderson GN, de Marco T, Chatterjee K Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.

Fragasso G Deranged cardiac metabolism and the pathogenesis of heart failure. Card Fail Rev — Kantor PF, Lucien A, Kozak R, Lopaschuk GD The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.

Eur Heart J — Sabbah HN, Chandler MP, Mishima T, Suzuki G, Chaudhry P, Nass O, Biesiadecki BJ, Blackburn B, Wolff A, Stanley WC Ranolazine, a partial fatty acid oxidation pFOX inhibitor, improves left ventricular function in dogs with chronic heart failure.

J Card Fail — Gordon A, Hultman E, Kaijser L, Kristjansson S, Rolf CJ, Nyquist O, Sylvén C Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res — PMID: Santacruz L, Arciniegas AJL, Darrabie M, Mantilla JG, Baron RM, Bowles DE, Mishra R, Jacobs DO Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation.

Physiol Rep 5:e Sciatti E, Lombardi C, Ravera A, Vizzardi E, Bonadei I, Carubelli V, Gorga E, Metra M Nutritional deficiency in patients with heart failure.

Nutrients Article CAS PubMed Central Google Scholar. Fumagalli S, Fattirolli F, Guarducci L, Cellai T, Baldasseroni S, Tarantini F, Di Bari M, Masotti G, Marchionni N Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study. Clin Cardiol — Lombardi C, Carubelli V, Lazzarini V, Vizzardi E, Bordonali T, Ciccarese C, Castrini AI, Dei Cas A, Nodari S, Metra M Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure.

Nutrition — J Int Soc Sports Nutr Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure.

Adv Ther — Landoni G, Zangrillo A, Lomivorotov VV, Likhvantsev V, Ma J, De Simone F, Fominskiy E Cardiac protection with phosphocreatine: a meta-analysis. Interact Cardiovasc Thorac Surg — Snow RJ, Murphy RM Creatine and the creatine transporter: a review.

Mol Cell Biochem — Elgebaly SA, Poston R, Todd R, Helmy T, Almaghraby AM, Elbayoumi T, Kreutzer DL Cyclocreatine protects against ischemic injury and enhances cardiac recovery during early reperfusion.

Expert Rev Cardiovasc Ther — Cacciante F, Gennaro M, Sagona G, Mazziotti R, Lupori L, Cerri E, Putignano E, Butt M, Do MT, McKew JC, Alessandrì MG, Battini R, Cioni G, Pizzorusso T, Baroncelli L Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency.

Sci Rep Osbakken M, Ito K, Zhang D, Ponomarenko I, Ivanics T, Jahngen EG, Cohn M Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart. Cardiology — Houser SL, Elkerm AF, Wei Z, Doyle K, Houser D, Liu XK, Tyles E, Kaddurah-Daouk R, Elgebaly SA Enhancement of cardiac function by cyclocreatine in models of cardiopulmonary bypass.

Download references. Annamaria Del Franco, Fabio A. Division of Cardiology, School of Medicine, University of Perugia, Perugia, Italy. Institute of Neuroscience, National Research Council CNR , Pisa, Italy.

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Calambrone, PI, Italy. Division of Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Andrea Barison, Yu F. Cardiomyopathy Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy. Lewis Katz School of Medicine, Cardiovascular Research Center, Temple University, Philadelphia, PA, USA.

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University and Civil Hospital, Brescia, Italy. You can also search for this author in PubMed Google Scholar.

Correspondence to Michele Emdin. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.

The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

Reprints and permissions. Del Franco, A. et al. Creatine deficiency and heart failure. Heart Fail Rev 27 , — Download citation.

Accepted : 08 September Published : 07 October Issue Date : September Anyone you share the following link with will be able to read this content:. Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative. Download PDF. Abstract Impaired cardiac energy metabolism has been proposed as a mechanism common to different heart failure aetiologies. The Myocardial Creatine Kinase System in the Normal, Ischaemic and Failing Heart Chapter © The Failing Heart: Is It an Inefficient Engine or an Engine Out of Fuel?

Chapter © Metabolic remodelling in heart failure Article 18 June Use our pre-submission checklist Avoid common mistakes on your manuscript. Biochemistry of creatine Creatine Cr is a guanidino compound that plays a vital role in the energy metabolism of cells.

Full size image. Physiology of creatine and phosphocreatine in cardiomyocytes Chemical energy in the form of ATP is produced from multiple substrates principally long-chain fatty acids, lactate, and glucose , predominantly in the mitochondria via oxidative phosphorylation.

Assessment of cardiac creatine metabolism Magnetic resonance spectroscopy MRS is the only technique capable to non-invasively measure the ratios and concentrations of endogenous cardiac high-energy phosphate metabolites and CK flux in human hearts.

Creatine deficiency in heart failure According to the energy starvation hypothesis, altered myocardial metabolism anticipates and sustains contractile dysfunction [ 23 ]. Exercise training and creatine kinase system Training increases exercise capacity, quality of life, and reduces morbidity and mortality in HF by improving endothelial function and coronary perfusion, decreasing peripheral resistance and ventricular remodelling, as well as neuro-endocrine and pro-inflammatory activation [ 43 ].

Pharmacological approaches to improve cardiac metabolism in heart failure Neurohormonal antagonists are the cornerstone of pharmacological therapy of HF.

Table 1 Clinical studies on supplementation of creatine Cr or phosphocreatine PCr in patients with acute or chronic heart failure HF. NYHA, New York Heart Association; RCT, randomized clinical trial. References provided in Supplemental Material Full size table.

Conclusions As a component of the energy buffer system, Cr is involved in cardiac metabolism to transfer energy from site of production to site of utilization. Central illustration Failing heart shows a decreased creatine Cr content and creatine kinase CK activity, as well as a reduced expression of Cr transporter.

Data availability Not applicable. Code availability Not applicable. Abbreviations ADP: Adenosine diphosphate ATP: Adenosine triphosphate AGAT: L-arginine:glycine amidinotransferase Cr: Creatine CK: Creatine kinase CrT: Creatine transporter GA: Guanidinoacetate GAMT: S-adenosyl-L-methionine:guanidinoacetate N-methyltransferase HF: Heart failure MRS: Magnetic resonance spectroscopy PCr: Phosphocreatine.

References Wallimann T, Tokarska-Schlattner M, Schlattner U The creatine kinase system and pleiotropic effects of creatine. emrstm Hansch A, Rzanny R, Heyne JP, Leder U, Reichenbach JR, Kaiser WA Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using 31P spectroscopic chemical shift imaging.

d9 Article CAS PubMed Google Scholar Zhou B, Tian R Mitochondrial dysfunction in pathophysiology of heart failure. H Article CAS PubMed Google Scholar Zweier JL, Jacobus WE, Korecky B, Brandejs-Barry Y Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding.

Creatine is an amino acid compound found in muscle cells where it aids in the regeneration of ATP, or energy production. Creatine monohydrate the most popular and researched form is a creatine molecule with one additional water molecule which helps your cells absorb and retain water for hydration.

To put it simply, creatine is an energy source for muscle cells and helps in performance and recovery. Creatine monohydrate supplementation safely increases the stores of the compound in muscle cells to the maximum amount.

How much should I take?. A study done in used 16 clinical trials from over a decade to conclude that in participants, creatine supplementation undoubtedly out-performed placebo in muscle growth and strength. There are also new studies being conducted to show that creatine might be an essential part of healthy heart function.

Another study theorized that because failing hearts typically show a decrease in creatine transportation, it could be beneficial to supplement. Even though the findings were not conclusive, they were deemed to be encouraging and warrant future research.

How much should I take? Most research has been conducted using an average of grams per day, this is a safe amount. Keep in mind that a small percentage of the population actually produces creatine to the maximum extent — these people will see little to no benefit from supplementation.

Is it possible to take too much creatine? Creatine is a phosphate donor, existence of which is essential for an adequate level of intracellular adenosine triphosphate ATP Different studies reported that serum levels of creatine phosphate are reduced during cardiac failure and the proportion of creatine to ATP is a better predictive factor for left ventricular ejection fraction Although, several review studies have reported the beneficial effects of creatine monohydrate in CHF patients; however, the associated mechanisms are still unknown For example, Witte and Clark investigated the effects of q10 coenzyme and creatine monohydrate on respiratory criteria and physical functions of respiratory system among CHF patients and reported that the intervention group had a better oxygen saturation rate than the control group and also patients receiving these complements had significantly better physical activities compared to the control group These results were in accordance with the findings of the current study.

The same results were also reported by Allard and others who also reported an increase in the peak VO 2 , anaerobic threshold and O 2 pulse in addition to aforesaid conditions among HF patients Most studies have reported the beneficial effects of exercise on inflammatory process and endothelial dysfunction among patients with cardiovascular diseases.

For example an in vitro study on rats reported that the endothelium dependent vasorelaxation to acetylcholine was reduced significantly in diabetic animals and exercise training or grape seed extract administration partially improves this response. Also, the combination of exercise training with grape seed extract restored the endothelial function completely The results of this study could indicate the beneficial effects of exercise and anti-oxidant compounds on the chronic diseases related to endothelial dysfunction such as cardio vascular diseases.

Some other studies have also reported the anti-oxidant properties 34 , improvement of endothelial dysfunction 35 and anti-inflammatory effects 36 of exercise, alone, among patients with heart failure. A review study by Babista and co-workers reported that exercise and physical activities could improve chronic inflammation, inhibit the pre-inflammatory cytokine generation and reduce the oxidative stress among HF patients Linke and others showed that exercise could reduce the oxidative stress in skeletal muscles of patients with HF, via increasing the activities of scavenger enzymes Also, Fu and colleagues reported that regular walking improves the pulse rates of CHF patients considerably in comparison with control patients.

They also reported that walking could decrease homocystein, improve the lifestyle and endothelial function among intervention group patients of HF compared to control group These results were in accordance with the findings of our study. A study performed by Erbs and others on CHF patients reported that 12 weeks exercise resulted in improvement of the vasomotor function of peripheral vessels, improvement of left ventricular function and ejection fraction, revival of neovascularisation for skeletal muscles and endothelial function There were no studies in the literature to show the effects of creatine monohydrate on the inflammatory characteristics or endothelial dysfunction in HF patients and most studies have shown the effects of this complement on the contraction of cardiac muscles or on the ergogenic properties of creatine 18 , 38 , All these beneficial effects have been associated with only regular exercise among HF patients and mostly were in accordance with our findings.

In addition to regular exercise we investigated a combination of this physical activity and application of an essential micronutrient among HF patients. This is the first study to investigate the effects of this combination among HF patients and this pilot study revealed an effective role of this combination for HF patients among the interventional group compared to control group.

One of the limitations of the current study was the lack of evaluation of participants for left ventricular function and ejection fraction via echocardiography. According to the findings of this study, combination of creatine monohydrate and regular exercise can improve the inflammatory process and endothelial function of patients with chronic heart failure.

Therefore, this method can be suggested as a nondrug treatment for control of destructive effects, created by inflammatory process and endothelial dysfunction, among CHF patients. Soukoulis V, Dihu JB, Sole M, Anker SD, Cleland J, Fonarow GC, et al.

Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study.

Butler J, Kalogeropoulos A, Georgiopoulou V, Belue R, Rodondi N, Garcia M, et al. Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail. Marchionni N, Di Bari M, Fumagalli S, Ferrucci L, Baldereschi G, Timpanelli M, et al.

Variable effect of comorbidity on the association of chronic cardiac failure with disability in community-dwelling older persons.

Arch Gerontol Geriatr. Masoudi FA, Rumsfeld JS, Havranek EP, House JA, Peterson ED, Krumholz HM, et al.

Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail. Rodriguez-Artalejo F, Guallar-Castillon P, Pascual CR, Otero CM, Montes AO, Garcia AN, et al.

Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med. Heo S, Moser DK, Lennie TA, Zambroski CH, Chung ML. A comparison of health-related quality of life between older adults with heart failure and healthy older adults.

Heart Lung. Witte KKA, Clark AL, Cleland JGF. Chronic heart failure and micronutrients. J Am College Cardiol. Berezin AE, Kremzer AA, Samura TA, Martovitskaya YV. Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes.

Int Cardiovasc Res J. Badavi M, Abedi HA, Sarkaki AR, Dianat M. Co-administration of Grape Seed Extract and Exercise Training Improves Endothelial Dysfunction of Coronary Vascular Bed of STZ-Induced Diabetic Rats. Iran Red Crescent Med J.

Michowitz Y, Arbel Y, Wexler D, Sheps D, Rogowski O, Shapira I, et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure.

Int J Cardiol. Shah SJ, Marcus GM, Gerber IL, McKeown BH, Vessey JC, Jordan MV, et al. High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. Vescovo G, Ravara B, Gobbo V, Sandri M, Angelini A, Della Barbera M, et al. L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure.

Am J Physiol Cell Physiol. Tulchinsky TH. Micronutrient deficiency conditions: global health issues. Public Health Rev. Felker GM. Coenzyme Q10 and statins in heart failure: the dog that didn't bark. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism.

Physiol Rev. Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev. Ferraro S, Maddalena G, Fazio S, Santomauro M, Lo Storto M, Codella C, et al. Acute and short-term efficacy of high doses of creatine phosphate in the treatment of cardiac failure.

Current Ther Res. Mancini DM, Ferraro N, Tuchler M, Chance B, Wilson JR. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus nuclear magnetic resonance. Am J Cardiol. Kuethe F, Krack A, Richartz BM, Figulla HR. Creatine supplementation improves muscle strength in patients with congestive heart failure.

Gordon A, Hultman E, Kaijser L, Kristjansson S, Rolf CJ, Nyquist O, et al.

Carviovascular then, creatine has had both good and bad Creatie. There Endurance nutrition for athletes those who have sought to ban it as an cariovascular performance enhancing substance, while many have been proponents Creatine and cardiovascular health it as a cardiovazcular and Creatine and cardiovascular health product for athletes. But, who is right? Is creatine safe or should athletes use caution? Moreover, for the purpose of this article, what is its effect on the heart, if any? Creatine is a combination of the three amino acids, glycine, arginine, and methionine, and is produced by our own bodies. This same process that occurs in our bodies to produce creatine also happens inside animals we eat, such as herring, salmon, tuna, and beef. how cardiovascupar cite: Speed optimization consultancy F, Creatine and cardiovascular health Creatin, Asadollahi K, Cardiovsscular K, Creatine and cardiovascular health Cretaine. Effects of Complementary Carsiovascular Creatine and cardiovascular health cardiovscular Physical Training on Inflammatory and Endothelial Dysfunction Markers Among Heart Failure Patients. Asian J Sports Med. Heart Failure Creatine Monohydrate Exercise Inflammatory Markers Endothelial Dysfunction. Heart failure HF is one of the main health problems among all societies; the prevalence of which increases along with age 1 and due to aging population 23. In addition to higher mortality rate, higher costs of HF associated with recurrent hospitalization accompanied with disability 4lower exercise tolerance 5 and lower health related quality of life HRQL are among CHF outcomes 6 - 8. Creatine and cardiovascular health

Author: Vijinn

4 thoughts on “Creatine and cardiovascular health

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com